Insmed - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsInsmed

Insmed(INSM)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Arikayce	Amikacin	2018-09-28	2024-2035	Respiratory tract infections , Urinary tract infections , Bacterial infections , Intraabdominal infections , Pseudomonas infections , Infectious skin diseases , Escherichia coli infections , Soft tissue infections , Surgical wound infection , Staphylococcal infections , Burns , Endocarditis , Central nervous system infections , Proteus infections , Infectious bone diseases , Acinetobacter infections , Klebsiella infections , Mycobacterium infections , Serratia infections
Iplex	Mecasermin rinfabate	2005-12-12		—

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

,

respiratory aspiration

,

,

,

nontuberculous mycobacteria

,

,

cystic fibrosis

,

,

nontuberculous mycobacterium infections

,

mycobacterium infections

,

persistent infection

,

communicable diseases

,

mycobacterium avium-intracellulare infection

,

pseudomonas infections

Mecasermin rinfabate

myotonic dystrophy

,

,

myotonic dystrophy

bacterial infections

,

anxiety disorders

,

depressive disorder

,

chronic obstructive pulmonary disease

,

,

bipolar disorder

,

,

type 2 diabetes mellitus

,

,

,

obstructive lung diseases

,

sleep initiation and maintenance disorders

,

,

non-alcoholic fatty liver disease

,

healthy volunteers/patients

,

renal insufficiency

,

,

hepatic insufficiency

,

cystic fibrosis

,

,

,

,

,

hidradenitis suppurativa

,

,

,

,

Aglatimagene besadenovec

prostatic hyperplasia

,

,

erectile dysfunction

Sodium chloride

healthy volunteers/patients

,

,

major depressive disorder

,

depressive disorder

,

prostatic hyperplasia

,

,

knee osteoarthritis

,

,

,

,

carpal tunnel syndrome

,

,

premature birth

,

premature ejaculation

,

,

,

,

penile induration

,

,

thoracic outlet syndrome

,

amyotrophic lateral sclerosis

,

motor neuron disease

,

,

musculoskeletal pain

,

systemic lupus erythematosus

,

,

,

,

dystonic disorders

,

,

myofascial pain syndromes

,

,

somatoform disorders

,

,

parkinson disease

,

temporomandibular joint disorders

,

,

temporomandibular joint dysfunction syndrome

,

,

systemic scleroderma

,

raynaud disease

,

localized scleroderma

,

diffuse scleroderma

,

urinary bladder diseases

,

multiple sclerosis

,

neurogenic urinary bladder

,

,

breast neoplasms

,

,

postoperative pain

,

breast diseases

,

hereditary breast and ovarian cancer syndrome

,

,

patellofemoral pain syndrome

,

,

chronic disease

,

overactive urinary bladder

,

muscle spasticity

,

,

migraine disorders

,

urinary incontinence

,

,

,

interstitial cystitis

,

,

,

,

wounds and injuries

,

,

,

,

,

graves ophthalmopathy

,

spinal cord injuries

,

microbial drug resistance

,

,

,

postoperative nausea and vomiting

,

bariatric surgery

,

,

,

keratoconjunctivitis sicca

,

dry eye syndromes

,

,

herpes labialis

,

breast implants

,

,

intraocular pressure

,

muscle strength

,

clostridium botulinum type a

healthy volunteers/patients

diabetes mellitus

,

type 1 diabetes mellitus

,

type 2 diabetes mellitus

Microcrystalline cellulose

type 2 diabetes mellitus

,

diabetes mellitus

diabetes mellitus

,

type 1 diabetes mellitus

,

type 2 diabetes mellitus

,

cystic fibrosis

drug interactions

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use